Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer's Disease Biotech Investing
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference Pharmaceutical Investing
Innovotech Inc. Reports Results For Its Second Quarter And Half-Year Ended 30 June 2025 Biotech Investing
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer Medical Device Investing
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
Inhibikase Therapeutics Strengthens Leadership Team with Appointment of Timothy Pigot as Chief Commercial and Strategy Officer Biotech Investing
